Reversible posterior leukoencephalopathy: Report of two cases after vincristine treatment;Leucoencefalopatía posterior reversible: Descripción de dos casos asociados a vincristina

Anales de Pediatria

Volumn 68, Issue 3, 2008, Pages 282-285

  Hualde Olascoaga, J ^a   Molins Castiella, T ^a   Souto Hernandez S ^a   Becerril Moreno, F ^a   Yoldi Petri, M E ^a   Sagaseta De Ilurdoz, M ^a   Molina Garicano, J ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Cerebral edema; Hypertension; Magnetic resonance imaging; Posterior reversible leukoencephalopathy

Indexed keywords

ASPARAGINASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; DRUG MEGADOSE; FEMALE; HUMAN; LEUKOENCEPHALOPATHY;

EID: 41549159783     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13116711     Document Type: Article

References (16)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Eng J Med. 1996;22:494-500.
2. Morris EB, Lanningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer. 2007;4:152-9.
3. Casali-Rey JI, Dávalos EG, López-Amalfara A, Julio-Muñoz D, Pagano MA. Síndrome de encefalopatía posterior reversible: presentación de casos clínicos. Rev Neurol. 2003;37:224-7.
4. Eguchi K, Kashara K, Nagashima A, Mor T, Nii T, Ibaraki K, et al. Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure riser pattern. Hypertens Res. 2002;25:467-73.
5. Froehlich T, Sandifer S, Varma PK, Testa FM. Two cases of hypertension-induced reversible posterior leukoencephalopathy syndrome secondary to glomerulonephritis. Curr Opin Pediatr. 1999;11:512-8.
6. Suminoe A, Matsuzaki A, Kira R, Fukunaga N, Nishio T, Hoshina T, et al. Reversible posterior leukoencephalopathy syndrome in children with cancers. J Pediatr Hematol Oncol. 2003;25:236-9.
7. Molina J, De Sagaseta IM, Yoldi ME, Gallinas F, Hernández T. Reversible posterior leukoencephalopathy syndrome in a girl with central nervous system leukaemia. Pediatr Blood Cancer. 2004;43:469.
8. Alurralde AM, Egidio M, Saizar R, Consalvo D, Villa AM. Leucoencefalopatía posterior reversible: descripción de un caso y revisión de la fisiopatología basada en hallazgos neurorradiológicos. Rev Neurol. 2004;38:541-4.
9. Ay H, Buonanno FS, Schaefer PW, Le DA, Wang B, González RG, et al. Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology. 1998;51:1369-76.
10. Casey SO, Sampaio RC, Michel E, Truwit CHL. Posterior encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol. 2000;21:1199-206.
11. Oliverio PJ, Restrepo L, Mitchel SA, Tornatore CS, Frankel S. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. AJNR. 2000;21:1251-4.
12. Romano LM, De Robles P, Ioli P, García-Saiz E. Síndrome de leucoencefalopatía posterior reversible por cisplatino. Presentación de un caso. Rev Neurol. 2005;41:573-4.
13. Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: Magnetic resonance imaging findings. Epilepsia. 1998;39:295-9.
14. López-García F, Amorós-Martínez F, Sempere AP. Síndrome de leucoencefalopatía posterior reversible. Rev Neurol. 2004;38:261-6.
15. Honkaniemi J, Kahara V, Dastidar P, Latvala M, Hietaharju A, Salonen T. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology. 2000;42:895-9.
16. Cho SG, Moon H, Lee JH. Behenoyl cytarabin-associated reversible encephalopathy in a patient with acute myeloid leucemia. J Korean Med Sci. 1999;14:89-92.